GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression

Chaolong Yan,Zijiang Yang,Pin Chen,Yuyang Yeh,Chongjing Sun,Tao Xie,Wei Huang,Xiaobiao Zhang
DOI: https://doi.org/10.1186/s13046-024-03025-8
IF: 12.658
2024-04-05
Journal of Experimental & Clinical Cancer Research
Abstract:Lactate has emerged as a critical regulator within the tumor microenvironment, including glioma. However, the precise mechanisms underlying how lactate influences the communication between tumor cells and tumor-associated macrophages (TAMs), the most abundant immune cells in glioma, remain poorly understood. This study aims to elucidate the impact of tumor-derived lactate on TAMs and investigate the regulatory pathways governing TAM-mediated tumor-promotion in glioma.
oncology
What problem does this paper attempt to address?
The paper primarily discusses the mechanism of lactate in the tumor microenvironment of gliomas and its impact on tumor-associated macrophages (TAMs). Specifically, the paper aims to address the following key questions: 1. **Upregulation of lactate metabolism in gliomas and its relationship with M2-type TAM infiltration**: The study found that lactate dehydrogenase A (LDHA) and monocarboxylate transporter 1 (MCT1) are upregulated in gliomas, which is associated with increased lactate metabolism and acidification of the tumor microenvironment. The high expression of LDHA and MCT1 is positively correlated with the infiltration of M2-type TAMs, which are known to promote tumor progression. 2. **Lactate derived from tumor cells induces M2 polarization in TAMs**: In vitro experiments using conditioned culture medium showed that lactate produced by glioma cells can induce macrophages to polarize into M2-type, and these polarized macrophages further promote glioma cell proliferation, migration, and invasion. 3. **GPR65 mediates lactate signaling and triggers HMGB1 release**: The study identified G-protein coupled receptor 65 (GPR65) as the main receptor on TAMs in response to lactate stimulation. It triggers the release of high mobility group box 1 protein (HMGB1) through the cAMP/PKA/CREB signaling pathway, thereby promoting malignant progression of gliomas. 4. **Blocking the lactate-HMGB1 feedback loop as a therapeutic strategy**: The paper suggests that breaking this feedback loop, which promotes tumor progression, can be achieved through downregulation of GPR65 or inhibition of HMGB1. This may provide new targets for the treatment of glioblastoma (GBM). In conclusion, the paper reveals the dynamic interaction between lactate and HMGB1 in the progression of gliomas, particularly how they promote tumor development by regulating the function of TAMs. Intervention strategies targeting GPR65 or HMGB1 are proposed as potential therapeutic approaches.